Gene: CYP2C9 ×
Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1559
Gene Symbol: CYP2C9
CYP2C9 		0.060 GeneticVariation disease BEFREE In conclusion, there is evidence to indicate a significant association between CYP2C9 430C>T polymorphism and CRC/CRA risk. 24414392 2014
Entrez Id: 1559
Gene Symbol: CYP2C9
CYP2C9 		0.060 GeneticVariation disease BEFREE CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment. 23081681 2013
Entrez Id: 1559
Gene Symbol: CYP2C9
CYP2C9 		0.060 GeneticVariation disease BEFREE We examined the relationship between UGT1A6 and CYP2C9 genotype and colorectal adenoma recurrence in 546 patients participating in a randomized placebo-controlled aspirin intervention trial. 17085674 2006
Entrez Id: 1559
Gene Symbol: CYP2C9
CYP2C9 		0.060 GeneticVariation disease BEFREE Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. 19233181 2009
Entrez Id: 1559
Gene Symbol: CYP2C9
CYP2C9 		0.060 GeneticVariation disease BEFREE Polymorphisms in the CYP2C9 enzyme are associated with elevated risk for colorectal adenoma. 15290664 2004
Entrez Id: 1559
Gene Symbol: CYP2C9
CYP2C9 		0.060 Biomarker disease BEFREE P450 CYP2C9*3 heterozygotes had reduced CRA risk compared with homozygotes for the reference allele [odds ratio (OR): 0.60; 95% confidence interval (CI): 0.36-0.99], whereas CYP2D6*4 homozygotes (OR: 2.72; 95% CI: 1.18-6.27) and GSTM1 'null' individuals (OR: 1.43; 95% CI: 1.04-1.98) were at increased risk. 20375710 2010